BEVACIZUMAB
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | BEVACIZUMAB |
| DrugBank ID | DB00112 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 15 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| ankylosing spondylitis | TxGNN Knowledge Graph | L5 |
| juvenile arthritis due to defect in lacc1 | TxGNN Knowledge Graph | L5 |
| spondyloarthropathy | TxGNN Knowledge Graph | L5 |
| rheumatoid arthritis | TxGNN Knowledge Graph | L5 |
| psoriatic arthritis | TxGNN Knowledge Graph | L5 |
| spondyloarthropathy, susceptibility to | TxGNN Knowledge Graph | L5 |
| juvenile idiopathic arthritis | TxGNN Knowledge Graph | L5 |
| relapsing-remitting multiple sclerosis | TxGNN Knowledge Graph | L5 |
| respiratory syncytial virus infectious disease | TxGNN Knowledge Graph | L5 |
| colorectal cancer | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11